Učitavanje...

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

BACKGROUND: It is important to establish the cardiovascular (CV) safety profile of novel antidiabetic drugs. METHODS: Pooled analyses were performed of 20 randomized controlled studies (N = 9156) of saxagliptin as monotherapy or add-on therapy in patients with type 2 diabetes mellitus (T2DM) as well...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Iqbal, Nayyar, Parker, Artist, Frederich, Robert, Donovan, Mark, Hirshberg, Boaz
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3918110/
https://ncbi.nlm.nih.gov/pubmed/24490835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-13-33
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!